| Pharmaceutical active ingredients: |
| Insulin Zinc Suspension Porcine amorphous highly purified |
| Available forms, composition and doses of Insuline Semi Tardum: |
| N / A |
| Insuline Semi Tardum medical category: |
| Human:Insulin preparations |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A10AB03 - Insulin (Pork)A10AC03 - Insulin (Pork)A10AD03 - Insulin (Pork)A10AE03 - Insulin (Pork) |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Organon |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Novolin Lente | Insulin Zinc Suspension Human, pyr crystalline | Novo Nordisk |
| Novolin Ultralente | Insulin Zinc Suspension Human, pyr crystalline | Novo Nordisk |
| Insulin Novo Semilente MC | Insulin Zinc Suspension Porcine | Novo Nordisk |
| Lente L | Insulin Zinc Suspension Porcine | Novo Nordisk |
| Semilen MC | Insulin Zinc Suspension Porcine amorphous | Novo Nordisk |
| Insulin LT | Insulin Zinc Suspension Porcine amorphous; Insulin Zinc Suspension Porcine crystalline | Polfa Tarchomin |
| Levulin L | Insulin Zinc Suspension Porcine amorphous; Insulin Zinc Suspension Porcine crystalline | Marvel LifeSciences |
| Endopancrine 100 | Insulin Zinc Suspension Porcine highly purified | Organon |
| Neosulin Lenta | Insulin Zinc Suspension Porcine monocomponent | Novo Nordisk |
| Semilente MC | Insulin Zinc Suspension Porcine monocomponent amorphous | Novo Nordisk |